Guiyang Xintian Pharmaceutical Co Ltd Total Assets
Guiyang Xintian Pharmaceutical Co Ltd total assets. Based on the latest financial reports, Guiyang Xintian Pharmaceutical Co Ltd (002873) holds total assets worth CN¥2.09 Billion CNY (≈ $306.09 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Guiyang Xintian Pharmaceutical Co Ltd stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)
Total assets of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025. This chart illustrates how Guiyang Xintian Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Guiyang Xintian Pharmaceutical Co Ltd for real-time trading data and today's change.
Guiyang Xintian Pharmaceutical Co Ltd - Asset Composition Analysis
Guiyang Xintian Pharmaceutical Co Ltd Total Assets Breakdown (December 2025)
Guiyang Xintian Pharmaceutical Co Ltd total assets breakdown as of December 2025. Guiyang Xintian Pharmaceutical Co Ltd's total assets of CN¥2.09 Billion consist of 30.7% current assets and 69.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 8.2% |
| Accounts Receivable | CN¥268.40 Million | 12.7% |
| Inventory | CN¥172.11 Million | 8.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥201.05 Million | 9.5% |
| Goodwill | CN¥6.19 Million | 0.3% |
Asset Composition Trend (2012–2025)
This chart illustrates how Guiyang Xintian Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Guiyang Xintian Pharmaceutical Co Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guiyang Xintian Pharmaceutical Co Ltd's current assets represent 30.7% of total assets in 2025, a decrease from 61.6% in 2012.
- Cash Position: Cash and equivalents constituted 8.2% of total assets in 2025, down from 12.8% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 25.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 12.7% of total assets.
Guiyang Xintian Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Guiyang Xintian Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
Verona Pharma plc
F:I9SA
|
Germany | €572.87 Million |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA
|
USA | $641.76 Million |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥37.46 Billion |
|
Metsera, Inc. Common Stock
NASDAQ:MTSR
|
USA | $639.66 Million |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
Bavarian Nordic
CO:BAVA
|
Denmark | Dkr14.95 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
Guiyang Xintian Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.34 | 2.16 | 1.50 |
| Quick Ratio | 0.99 | 1.68 | 1.28 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥156.90 Million | CN¥315.89 Million | CN¥239.53 Million |
Guiyang Xintian Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guiyang Xintian Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.61 |
| Latest Market Cap to Assets Ratio | 0.13 |
| Asset Growth Rate (YoY) | 8.7% |
| Total Assets | CN¥2.12 Billion |
| Market Capitalization | $268.97 Million USD |
Valuation Analysis
Below Book Valuation: The market values Guiyang Xintian Pharmaceutical Co Ltd's assets below their book value (0.13x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Guiyang Xintian Pharmaceutical Co Ltd's assets grew by 8.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Guiyang Xintian Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual total assets of Guiyang Xintian Pharmaceutical Co Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.12 Billion ≈ $310.38 Million |
+8.75% |
| 2024-12-31 | CN¥1.95 Billion ≈ $285.42 Million |
+2.02% |
| 2023-12-31 | CN¥1.91 Billion ≈ $279.76 Million |
+3.69% |
| 2022-12-31 | CN¥1.84 Billion ≈ $269.81 Million |
+20.95% |
| 2021-12-31 | CN¥1.52 Billion ≈ $223.07 Million |
-0.75% |
| 2020-12-31 | CN¥1.54 Billion ≈ $224.76 Million |
+41.74% |
| 2019-12-31 | CN¥1.08 Billion ≈ $158.57 Million |
+10.09% |
| 2018-12-31 | CN¥984.31 Million ≈ $144.04 Million |
+14.94% |
| 2017-12-31 | CN¥856.40 Million ≈ $125.32 Million |
+55.84% |
| 2016-12-31 | CN¥549.54 Million ≈ $80.41 Million |
+10.05% |
| 2015-12-31 | CN¥499.36 Million ≈ $73.07 Million |
+6.76% |
| 2014-12-31 | CN¥467.76 Million ≈ $68.45 Million |
+23.18% |
| 2013-12-31 | CN¥379.74 Million ≈ $55.57 Million |
+12.74% |
| 2012-12-31 | CN¥336.84 Million ≈ $49.29 Million |
-- |
About Guiyang Xintian Pharmaceutical Co Ltd
Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of … Read more